Subject: Another Positive Sales Increase for PSID's Caregiver Non-Contact Thermometer

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement., Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
Another Positive Sales Increase for PSID's Caregiver Non-Contact Thermometer
Hot Stock to WatchHot Stock to Watch

Company: PositiveID Corporation (OTCQB: PSID)


Price: 0.01

Change (%): + 0.0012 (13.38)

Volume: 2,320,253
PSID Chart

PositiveID’s Caregiver Average Monthly Sales Increase by 60% Among Customers Participating in National Group Buy Program

Vizient, Inc.’s National Group Buy Program Generates Significant Sales Increases for Caregiver

DELRAY BEACH, Fla., Oct. 24, 2016 (GLOBE NEWSWIRE) - PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a life sciences company focused on detection and diagnostics, announced today sales increased for its Caregiver® non-contact thermometer among accounts served by Vizient, Inc., the largest member-driven health care performance improvement company in the country, during its National Group Buy Program. Average monthly sales to Vizient’s customers increased approximately 60% during the second and third quarters of 2016, compared to average monthly sales to Vizient’s customers during the first quarter of 2016, when no National Group Buy program was in place for Caregiver.

Marketed by PositiveID’s Thermomedics subsidiary, Caregiver, which is FDA cleared for clinical use, is a professional grade, infrared thermometer for measurement of forehead temperature in adults, children, and infants, without contact. It delivers an oral-equivalent temperature directly from the forehead in one to two seconds. Since there is no skin contact and Caregiver does not require probe cover supplies, it reduces the risk of cross-contamination, which is an increasing concern, and saves healthcare facilities the cost of covers (as much as $0.05 to $0.10 per temperature), storage space, and waste disposal costs. It is estimated that Caregiver can offer savings of $250 or more per year per device in probe cover supplies alone.

“Being a part of programs like Vizient’s group buy is just one example of the types of improvements we continue to make as we focus on sales and marketing efforts for Caregiver following our acquisition of Thermomedics in December 2015,” stated William J. Caragol, Chairman and CEO of PositiveID. “We believe that as we expand our distribution channel, increase our participation at tradeshows, implement trials in hospitals, advertise, etc. we will see sustained sales growth for the Caregiver product.”

Vizient, Inc. is the largest member-driven health care performance improvement company in the country, and provides innovative data-driven solutions, expertise and collaborative opportunities that lead to improved patient outcomes and lower costs. Vizient’s diverse membership and customer base includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute health care providers and represents almost 100 billion dollars in annual purchasing volume. The National Group Buy program is one of several innovative programs from Vizient designed to deliver additional savings each quarter to the hospitals it serves.

Continue Reading

Like Us on FacebookFollow Us on Twitter

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks